Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADMA BIOLOGICS, INC. | Director | Common Stock | 2.12M | $22.9M | $10.80 | Nov 27, 2024 | Indirect |
ADMA BIOLOGICS, INC. | Director | Common Stock | 76.4K | $826K | $10.80 | Nov 27, 2024 | Direct |
ADMA BIOLOGICS, INC. | Director | Stock Option (Right to Buy) | 0 | $0 | $3.66 | Nov 27, 2024 | Direct |
Zosano Pharma Corp | Director | Common Stock | 2.72M | Jun 10, 2021 | (2) | ||
Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 35K | Jun 13, 2024 | Indirect | ||
Zosano Pharma Corp | Director | Stock Option (Right to Buy) | 30K | Jun 10, 2021 | Direct | ||
Zosano Pharma Corp | Director | Common Stock | 22.5K | Jun 10, 2021 | Direct | ||
Marker Therapeutics, Inc. | Director | Stock Option (right to buy) | 8K | Jun 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADMA | ADMA BIOLOGICS, INC. | Nov 27, 2024 | 2 | $97.2K | 4 | Dec 2, 2024 | Director |
ELEV | Elevation Oncology, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
ADMA | ADMA BIOLOGICS, INC. | Mar 18, 2024 | 2 | -$2.8M | 4 | Mar 19, 2024 | Director |
ADMA | ADMA BIOLOGICS, INC. | Mar 13, 2024 | 3 | -$6.34M | 4 | Mar 15, 2024 | Director |
ADMA | ADMA BIOLOGICS, INC. | Feb 26, 2024 | 2 | $0 | 4 | Feb 28, 2024 | Director |
MRKR | Marker Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
ADMA | ADMA BIOLOGICS, INC. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director |
MRKR | Marker Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
ADMA | ADMA BIOLOGICS, INC. | Mar 7, 2022 | 2 | $0 | 4 | Mar 9, 2022 | Director |
ZSAN | Zosano Pharma Corp | Jun 10, 2021 | 2 | $0 | 4 | Jun 14, 2021 | Director |
MRKR | Marker Therapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |